Voloridge Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.9M | Buy |
3,403,434
+142,888
| +4% | +$3.94M | 0.35% | 60 |
|
|
2025
Q1 | $92.4M | Buy |
3,260,546
+669,715
| +26% | +$19M | 0.34% | 75 |
|
|
2024
Q4 | $108M | Buy |
2,590,831
+1,996,003
| +336% | +$83M | 0.38% | 53 |
|
|
2024
Q3 | $39.8M | Buy |
+594,828
| New | +$39.8M | 0.14% | 211 |
|
|
2023
Q1 | – | Sell |
-175,961
| Closed | -$31.6M | – | 1522 |
|
|
2022
Q4 | $31.6M | Sell |
175,961
-75,942
| -30% | -$13.6M | 0.18% | 165 |
|
|
2022
Q3 | $29.8M | Buy |
251,903
+120,968
| +92% | +$14.3M | 0.16% | 181 |
|
|
2022
Q2 | $18.7M | Buy |
130,935
+105,619
| +417% | +$15.1M | 0.1% | 282 |
|
|
2022
Q1 | $4.36M | Sell |
25,316
-163,422
| -87% | -$28.2M | 0.02% | 683 |
|
|
2021
Q4 | $47.9M | Buy |
188,738
+119,068
| +171% | +$30.2M | 0.26% | 76 |
|
|
2021
Q3 | $26.8M | Sell |
69,670
-103,188
| -60% | -$39.7M | 0.17% | 134 |
|
|
2021
Q2 | $40.6M | Sell |
172,858
-19,268
| -10% | -$4.53M | 0.28% | 67 |
|
|
2021
Q1 | $25.2M | Sell |
192,126
-864,017
| -82% | -$113M | 0.18% | 143 |
|
|
2020
Q4 | $110M | Buy |
1,056,143
+675,609
| +178% | +$70.6M | 0.93% | 10 |
|
|
2020
Q3 | $26.9M | Buy |
+380,534
| New | +$26.9M | 0.22% | 108 |
|
|
2020
Q2 | – | Sell |
-59,304
| Closed | -$1.78M | – | 1415 |
|
|
2020
Q1 | $1.78M | Sell |
59,304
-101,943
| -63% | -$3.05M | 0.05% | 372 |
|
|
2019
Q4 | $3.15M | Buy |
+161,247
| New | +$3.15M | 0.06% | 386 |
|
|
2019
Q3 | – | Sell |
-29,111
| Closed | -$426K | – | 1165 |
|
|
2019
Q2 | $426K | Buy |
+29,111
| New | +$426K | 0.01% | 593 |
|